Evidence map›Paper›PMID 40553948›Full record

ArticleNeuroscience letters2025

Cocaine conditioning promotes persistent inhibition of GABAergic transmission in the mouse ventral hippocampal CA1 region.

Kyle A Brown, John J Wagner

Abstract read
In one paragraph

Article in Neuroscience letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kyle A BrownDepartment of Physiology & Pharmacology, University of Georgia, Athens, GA, USA; Interdisciplinary Toxicology Program, University of Georgia, Athens, GA, USA. Electronic address: Kyle.Brown@som.umaryland.edu.
John J WagnerDepartment of Physiology & Pharmacology, University of Georgia, Athens, GA, USA; Interdisciplinary Toxicology Program, University of Georgia, Athens, GA, USA; Neuroscience PhD Program, University of Georgia, Athens, GA, USA.

Funding

Cocaine-induced Metaplasticity in the HippocampusR01DA016302 · NIDA · UNIVERSITY OF GEORGIA (UGA) · PI WAGNER, JOHN J · 2003 to 2010
$1.1M
NIDA NIH HHS R01 DA016302
6 · The paper itself

Abstract

Millions of individuals globally meet the current diagnostic criteria for cocaine use disorder (CUD), and cocaine misuse contributes to thousands of overdose deaths every year in the United States. Current hypotheses suggest that cocaine misuse imparts a diminished ability for synaptic plasticity (i.e., drug-induced metaplasticity). This metaplasticity impairs adaptive learning, which has been proposed to contribute to the likelihood of cocaine relapse. Delineating plasticity processes that mediate drug-seeking behavior can facilitate the development of therapeutic interventions for CUD. We used behavioral pharmacology and ex vivo patch-clamp electrophysiology to test the hypothesis that escalating cocaine doses elicit long-lasting, drug-seeking behavior that is correlated with a persisting decrease of GABAergic transmission in the mouse ventral hippocampus (vH) CA1 region. We found that noncontingent cocaine conditioning reduced the amplitude of evoked inhibitory postsynaptic currents measured from vH CA1 pyramidal cells 4-5 weeks after the last dose, suggesting sustained synaptic disinhibition. The magnitude of drug-seeking behavior observed 4 weeks, but not 1 day, after cocaine abstinence predicted the extent of synaptic disinhibition. Persisting inhibition of GABAergic transmission occurred in the absence of altered IPSC kinetics. We conclude that cocaine conditioning evokes a progressive metaplasticity that persistently shifts the GABAergic tone of the vH CA1 region, and these synaptic actions are correlated with long-lasting drug-seeking behavior in mice. Our results suggest that targeting metaplastic processes that modulate vH neuronal excitability represents a promising therapeutic strategy for relieving symptoms associated with CUD.

Indexed as

CA1 Region, HippocampalCocaineGABAergic Neuronsgamma-Aminobutyric AcidSynaptic TransmissionAnimalsCocaine-Related DisordersDrug-Seeking BehaviorInhibitory Postsynaptic PotentialsMaleMiceMice, Inbred C57BLPyramidal CellsCocainegamma-Aminobutyric AcidCA1CocaineCocaine use disorderDisinhibitionHippocampusMetaplasticitySynaptic plasticity

Identifiers

PMID40553948
PMCPMC12270040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.